Loading clinical trials...
Loading clinical trials...
Neuroadrenergic Dysfunction Along the Diabetes Continuum: Benefits of Weight Loss Within Different Strata of Metabolic Risk
Conditions
Interventions
Dietary weight loss at 25% energy deficit
Locations
1
Australia
Baker IDI Heart & Diabetes Institute
Melbourne, Victoria, Australia
Start Date
April 1, 2013
Primary Completion Date
April 1, 2017
Completion Date
April 1, 2017
Last Updated
January 18, 2013
NCT07472881
NCT07051005
NCT01143454
NCT07296484
NCT07010757
NCT06223555
Lead Sponsor
Baker Heart Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions